Search research articles
Contact Us
Filters
Showing results (1-10 of 58) with videos related to
Page
of 6
Sort By:
Bulletin Du Cancer
|
December 8, 2010
[Molecularly targeted therapy in head and neck cancer]
C Le Tourneau
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 26, 2024
Paving the path towards tissue-agnostic drug approval in oncology
C Le Tourneau, I Bieche, M Kamal
Cancer Treatment Reviews
|
November 7, 2007
New developments in multitargeted therapy for patients with solid tumours
C Le Tourneau, S Faivre, E Raymond
Current Pharmaceutical Design
|
November 30, 2007
Aplidine: a paradigm of how to handle the activity and toxicity of a novel marine anticancer poison
C Le Tourneau, E Raymond, S Faivre
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 20, 2015
Statistical controversies in clinical research: requiem for the 3 + 3 design for phase I trials
X Paoletti, M Ezzalfani, C Le Tourneau
British Journal of Cancer
|
September 18, 2008
mTORC1 inhibitors: is temsirolimus in renal cancer telling us how they really work?
C Le Tourneau, S Faivre, M Serova, et al.
ESMO Real World Data and Digital Oncology
|
February 6, 2026
Core variables for real-world clinicogenomic data collection in precision oncology
R Dienstmann, A Hackshaw, J-Y Blay, et al.
Journal of Visceral Surgery
|
February 1, 2011
Targeted biotherapy in metastatic colorectal carcinoma: Current practice
W Cacheux, C Le Tourneau, B Baranger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 19, 2014
Designs of drug-combination phase I trials in oncology: a systematic review of the literature
M-K Riviere, C Le Tourneau, X Paoletti, et al.
British Journal of Cancer
|
January 28, 2012
Tumour growth kinetics assessment: added value to RECIST in cancer patients treated with molecularly targeted agents
C Le Tourneau, V Servois, V Diéras, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 58) with videos related to
Sort By:
Page
of 6
Bulletin Du Cancer
|
December 8, 2010
[Molecularly targeted therapy in head and neck cancer]
C Le Tourneau
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 26, 2024
Paving the path towards tissue-agnostic drug approval in oncology
C Le Tourneau, I Bieche, M Kamal
Cancer Treatment Reviews
|
November 7, 2007
New developments in multitargeted therapy for patients with solid tumours
C Le Tourneau, S Faivre, E Raymond
Current Pharmaceutical Design
|
November 30, 2007
Aplidine: a paradigm of how to handle the activity and toxicity of a novel marine anticancer poison
C Le Tourneau, E Raymond, S Faivre
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 20, 2015
Statistical controversies in clinical research: requiem for the 3 + 3 design for phase I trials
X Paoletti, M Ezzalfani, C Le Tourneau
British Journal of Cancer
|
September 18, 2008
mTORC1 inhibitors: is temsirolimus in renal cancer telling us how they really work?
C Le Tourneau, S Faivre, M Serova, et al.
ESMO Real World Data and Digital Oncology
|
February 6, 2026
Core variables for real-world clinicogenomic data collection in precision oncology
R Dienstmann, A Hackshaw, J-Y Blay, et al.
Journal of Visceral Surgery
|
February 1, 2011
Targeted biotherapy in metastatic colorectal carcinoma: Current practice
W Cacheux, C Le Tourneau, B Baranger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 19, 2014
Designs of drug-combination phase I trials in oncology: a systematic review of the literature
M-K Riviere, C Le Tourneau, X Paoletti, et al.
British Journal of Cancer
|
January 28, 2012
Tumour growth kinetics assessment: added value to RECIST in cancer patients treated with molecularly targeted agents
C Le Tourneau, V Servois, V Diéras, et al.
Page
of 6